Evidence map›Paper›PMID 38892731›Full record

ReviewJournal of clinical medicine2024

Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours.

Jodie L M Tham, Sweet Ping Ng, Richard Khor, Morikatsu Wada, Hui Gan, Alesha A Thai, June Corry, Houda Bahig, Antti A Mäkitie, Sandra Nuyts and 6 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jodie L M ThamDepartment of Radiation Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne 3084, Australia.
Sweet Ping NgDepartment of Radiation Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne 3084, Australia.ORCID 0000-0003-1721-0680
Richard KhorDepartment of Radiation Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne 3084, Australia.
Morikatsu WadaDepartment of Radiation Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne 3084, Australia.
Hui GanDepartment of Medical Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne 3084, Australia.
Alesha A ThaiDepartment of Medical Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne 3084, Australia.
June CorryGenesisCare, St Vincent's Hospital, Melbourne 3065, Australia.
Houda BahigDepartment of Radiation Oncology, Centre Hospitalier de L'Université de Montréal, Montreal, QC H2X 3E4, Canada.
Antti A MäkitieDepartment of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Research Program in Systems Oncology, Helsinki University Hospital, University of Helsinki, 00100 Helsinki, Finland.
Sandra NuytsDepartment of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-5540-4796
Remco De BreeDepartment of Otolaryngology-Head and Neck Surgery, VU University Medical Centre, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0001-7128-5814
Primož StrojanDepartment of Radiation Oncology, Institute of Oncology, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0445-112X
Wai Tong NgDepartment of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-6696-3000
Avraham EisbruchDepartment of Radiation Oncology, University of Michigan Medicine, Ann Arbor, MI 48109, USA.
James C H ChowDepartment of Clinical Oncology, Queens Elizabeth Hospital, Hong Kong SAR, China.
Alfio FerlitoInternational Head and Neck Scientific Group, 35100 Padua, Italy.ORCID 0000-0002-8247-8002

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of head and neck cancers (HNCs) encompasses a complex paradigm involving a combination of surgery, radiotherapy, and systemic treatment. Locoregional recurrence is a common cause of treatment failure, and few patients are suitable for salvage surgery. Reirradiation with conventional radiation techniques is challenging due to normal tissue tolerance limits and the risk of significant toxicities. Stereotactic body radiotherapy (SBRT) has emerged as a highly conformal modality that offers the potential for cure while limiting the dose to surrounding tissue. There is also growing research that shows that those with oligometastatic disease can benefit from curative intent local ablative therapies such as SBRT. This review will look at published evidence regarding the use of SBRT in locoregional recurrent and oligometastatic HNCs.

Indexed as

head and neck canceroligometastaticrecurrentreirradiationstereotactic body radiotherapy

Identifiers

PMID38892731
PMCPMC11173254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.